Different treatment options in COVID cases and role of Favipiravir in mild to moderate cases

Different treatment options in COVID cases and role of Favipiravir in mild to moderate cases

Coronavirus

90 Mins

English Site

Recorded Webinar

Online

Course Overview

 

Cases of COVID-19 are steadily rising in India, and because there is limited clinical experience around treatment options it becomes critical to share knowledge.

Indian Medical Association West Bengal welcomes doctors to a live clinical experience sharing recorded webinar session on “Different treatment options in COVID cases and role of Favipiravir in mild to moderate cases”

Inaugural address:
-Dr. Ujjwal Kumar Sengupta, President, IMA Bengal State

What was covered:
-Session 1: Role and challenge of Healthcare professionals to fight against the Pandemic by Dr. Santanu Sen, MBBS, DMRD, FRCP, MP, Immediate Past National President and State Secretary, IMA Bengal State
-Session 2: Different treatment options in COVID cases and Role of Favipiravir in mild to moderate cases by Dr. Sibabrata Banerjee, MBBS, MD, FICP, HOD, Medicine, Fortis Anandapur, Joint Secretary, IMA Bengal State

Moderator:
-Dr. Anirban Dalui, MBBS, MD, FCGP, Public Health Specialist

We thank the Indian Medical Association West Bengal, for hosting this session. We also thank our sponsors Mylan Pharmaceuticals Pvt. Ltd. to make this program possible. Wish you a great learning experience.


Trainers



Coming session Starts Oct 17, 2020
Ends Jan 17, 2021